Overview

Pharmacokinetic Study Comparing Aspirin and Aspirin Granules

Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
To determine the bioequivalence of new formula of aspirin relative to the established commercial aspirin plain tablet and aspirin dry granules when taken orally by healthy adult subjects
Phase:
Phase 1
Details
Lead Sponsor:
Bayer
Treatments:
Aspirin